- Lobbying
- Alec AND Hinojosa
Lobbying Arrangements Results for 'Alec Hinojosa'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Drug pricing; prescription drug transparency |
GoodRx
|
Faegre Baker Daniels Consulting | |||
Details Increase awareness of clinical use of FDA cleared prescription digital therapeutics. Medicare coverage of FDA cleared prescription digital therapeutics. |
Pear Therapeutics
|
Faegre Baker Daniels Consulting | |||
Details H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI Fiscal Year 2020 Labor HHS appropriations; funding for CDC, NIH and DOD focused on in... |
The Crohn's & Colitis Foundation
|
Faegre Baker Daniels Consulting | |||
Details Drug shortages Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019 Fiscal Year 2019 labor HHS appropriations legislation; issues relat... |
Thermo Fisher Scientific
|
Faegre Baker Daniels Consulting | |||
Details Funding for medical research; NIH funding; policies to enhance pediatric research activities; implementation of Trans-NIH Pediatric Research Consortium. Accelerating Kids' Access to Care Act and re... |
Boston Children's Hospital
|
Faegre Baker Daniels Consulting | |||
Details Fiscal Year 2020 Labor HHS appropriations and report language related to Pediatric Physician Scientist Training Program; implementation of Trans-NIH Pediatric Research Consortium; HR 4519: Pediatri... |
Coalition for Pediatric Medical Research
|
Faegre Baker Daniels Consulting | |||
Details Animal health , issues impacting medicines and vaccines for animals; ADUFA Reauthorization. (H.R. 1418; S. 1844, H.R. 5860). Monitor issues related to general corporate taxation; issues related to ... |
Zoetis
|
Williams and Jensen, PLLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. General education about federal policies impac... |
Sanofi, U.S.
|
Williams and Jensen, PLLC | |||
Details Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflat... |
Elevance Health, Inc. (formerly reported as Anthem, Inc.)
|
Williams and Jensen, PLLC | |||
Details Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. Matters affecting plasma donation and potential plasma... |
Plasma Protein Therapeutics Association
|
Williams and Jensen, PLLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing propos... |
PhRMA
|
Williams and Jensen, PLLC | |||
Details International and domestic tax issues. General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, an... |
Eli Lilly & Company
|
Williams and Jensen, PLLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug ... |
PFIZER
|
Williams and Jensen, PLLC | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying |